AAAAAA

   
Results: 1-9 |
Results: 9
EARLY DISCHARGE AND HOME CARE MANAGEMENT OF THERAPY-INDUCED NEUTROPENIC AML PATIENTS
Authors: CARTONI C CEDRONE M DEGREGORIIS C DESANCTIS V GIOVANNINI M NISCOLA P ROMANI C MOLETI ML ANDRIZZI C TOSTI S GIRMENIA C MANDELLI F
Citation: C. Cartoni et al., EARLY DISCHARGE AND HOME CARE MANAGEMENT OF THERAPY-INDUCED NEUTROPENIC AML PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 224-224
USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN COMBINATION WITH HYDROXYUREA AS POSTTRANSPLANT THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AUTOGRAFTED WITH UNMANIPULATED HEMATOPOIETIC-CELLS
Authors: CARLOSTELLA C REGAZZI E ANDRIZZI C SAVOLDO B GARAU D MONTEFUSCO E VIGNETTI M MANDELLI F RIZZOLI V MELONI G
Citation: C. Carlostella et al., USE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN COMBINATION WITH HYDROXYUREA AS POSTTRANSPLANT THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AUTOGRAFTED WITH UNMANIPULATED HEMATOPOIETIC-CELLS, Haematologica, 82(3), 1997, pp. 291-296
EFFECT OF CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA ON HEMATOPOIETIC AND FIBROBLAST MARROW PROGENITORS
Authors: CARLOSTELLA C TABILIO A REGAZZI E GARAU D LATAGLIATA R TRASARTI S ANDRIZZI C VIGNETTI M MELONI G
Citation: C. Carlostella et al., EFFECT OF CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA ON HEMATOPOIETIC AND FIBROBLAST MARROW PROGENITORS, Bone marrow transplantation, 20(6), 1997, pp. 465-471
INTERLEUKIN-2 FOR THE TREATMENT OF ADVANCED ACUTE MYELOGENOUS LEUKEMIA PATIENTS WITH LIMITED DISEASE - UPDATED EXPERIENCE WITH 20 CASES
Authors: MELONI G VIGNETTI M ANDRIZZI C CAPRIA S FOA R MANDELLI F
Citation: G. Meloni et al., INTERLEUKIN-2 FOR THE TREATMENT OF ADVANCED ACUTE MYELOGENOUS LEUKEMIA PATIENTS WITH LIMITED DISEASE - UPDATED EXPERIENCE WITH 20 CASES, Leukemia & lymphoma, 21(5-6), 1996, pp. 429-435
PROBABILITY OF LONG-TERM DISEASE-FREE SURVIVAL FOR ACUTE MYELOID-LEUKEMIA PATIENTS AFTER FIRST RELAPSE - A SINGLE-CENTER EXPERIENCE
Authors: VIGNETTI M ORSINI E PETTI MC MOLETI ML ANDRIZZI C PINTO RM AMADORI S MELONI G
Citation: M. Vignetti et al., PROBABILITY OF LONG-TERM DISEASE-FREE SURVIVAL FOR ACUTE MYELOID-LEUKEMIA PATIENTS AFTER FIRST RELAPSE - A SINGLE-CENTER EXPERIENCE, Annals of oncology, 7(9), 1996, pp. 933-938
AUTOIMMUNE HEMOLYTIC-ANEMIA IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA TREATED WITH LOW-DOSE INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: MELONI G ANDRIZZI C VIGNETTI M GIRELLI G MANDELLI F
Citation: G. Meloni et al., AUTOIMMUNE HEMOLYTIC-ANEMIA IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA TREATED WITH LOW-DOSE INTERLEUKIN-2 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 86(2), 1995, pp. 837-838
AUTOLOGOUS BMT IN 199 AML PATIENTS IN CR - 10-YEAR EXPERIENCE AT THE HEMATOLOGY OF THE UNIVERSITY-LA-SAPIENZA OF ROME, ITALY
Authors: MELONI G VIGNETTI M AVVISATI G ANDRIZZI C CAPRIA S ORSINI E SIMONE F TODISCO E VEGNA ML MANDELLI F
Citation: G. Meloni et al., AUTOLOGOUS BMT IN 199 AML PATIENTS IN CR - 10-YEAR EXPERIENCE AT THE HEMATOLOGY OF THE UNIVERSITY-LA-SAPIENZA OF ROME, ITALY, Blood, 84(10), 1994, pp. 10000202-10000202
INTERLEUKIN-2 TREATMENT IN ACUTE MYELOGENOUS LEUKEMIA
Authors: MANDELLI F VIGNETTI M TOSTI S ANDRIZZI C FOA R MELONI G
Citation: F. Mandelli et al., INTERLEUKIN-2 TREATMENT IN ACUTE MYELOGENOUS LEUKEMIA, Stem cells, 11(4), 1993, pp. 263-268
INTERLEUKIN-2 TREATMENT IN ACUTE MYELOBLASTIC-LEUKEMIA IN DIFFERENT PHASES OF DISEASE
Authors: MELONI G VIGNETTI M ANDRIZZI C CAPRIA S FOWST C BOTTONI A FOA R MANDELLI F
Citation: G. Meloni et al., INTERLEUKIN-2 TREATMENT IN ACUTE MYELOBLASTIC-LEUKEMIA IN DIFFERENT PHASES OF DISEASE, Blood, 82(10), 1993, pp. 10000543-10000543
Risultati: 1-9 |